We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abbott Enhances Expertise in Information Management with STARLIMS Acquisition

By LabMedica International staff writers
Posted on 21 Dec 2009
Abbott (Abbott Park, IL, USA) has signed an agreement to acquire STARLIMS Technologies Ltd. More...
(Tel Aviv, Israel), a provider of laboratory information-management systems, for approximately U.S. $123 million in cash. The acquisition strengthens Abbott's competitive position in the global diagnostics market, providing advanced web-based applications to help laboratories efficiently store, retrieve, and analyze clinical, managerial, and administrative data.

STARLIMS' web-based technologies will help Abbott customers to operate efficiently across the core laboratory, molecular, and point-of-care segments of the global diagnostics market. As the company is integrated into Abbott's existing portfolio of laboratory information-management products, STARLIMS will continue to support and expand the nonclinical market segments it currently serves.

"We believe our laboratory information management solutions, which are widely used by government, manufacturing and life sciences organizations, have important applications in clinical laboratories for improving the access, exchange and analysis of patient and technical data," said Itschak Friedman, CEO of STARLIMS, who will continue to lead the STARLIMS team after the acquisition closes.

Advanced informatics systems are becoming increasingly important to clinical laboratories as a means to automate the retrieval, communication, and management of medical and laboratory data and aid compliance with global regulatory and industry standards. Informatics systems help laboratories to improve their operating efficiency through process standardization, reduced labor costs, and increased capacity. Improved laboratory operations benefit physicians and patients through improved turnaround times and more consistent interpretation of test results.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of pharmaceutics and medical products, including diagnostics, devices, and nutritionals.

STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing, and life sciences organizations. The company's flagship product, STARLIMS improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities.

Related Links:

Abbott
STARLIMS Technologies Ltd.



New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Pipette Calibration System
Artel PCS®
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.